Menu Close

Summary*

Overjet, founded in 2018 and headquartered in Boston, Massachusetts, is a pioneering company in the dental artificial intelligence sector. The company has developed an innovative platform that leverages AI technology to enhance clinical care and streamline administrative processes for dental providers and payers. Overjet's primary focus is on radiographic analysis and claims processing optimization, serving a diverse clientele including dental service organizations (DSOs), dental groups, and insurance companies.

Since its inception, Overjet has demonstrated significant growth potential, having raised a total of $130.55 million in funding. This substantial financial backing underscores investor confidence in the company's vision and technology. Overjet's unique position in the healthcare technology sector, particularly in dental AI, positions it as a potentially attractive investment opportunity for those interested in emerging technologies within the healthcare industry.

As of now, there is no official information or confirmed reports regarding Overjet's plans for an initial public offering (IPO). The company's future plans for going public remain uncertain, and any discussions about a potential Overjet IPO should be considered speculative at this point. Investors interested in Overjet stock or looking to buy Overjet shares should be aware that the company is currently privately held, and investment opportunities may be limited.

Several factors could influence Overjet's decision to pursue an IPO in the future, including market conditions, the company's financial performance, and its growth trajectory. However, without concrete information or official announcements from the company, it's not possible to make any definitive statements about Overjet's IPO prospects or potential ticker symbol at this time.

How to invest in Overjet

While Overjet's IPO prospects remain uncertain, investors interested in the dental AI technology sector don't have to wait on the sidelines. At Linqto, we offer members access to interests in promising pre-IPO private companies like Overjet, potentially allowing you to benefit from their growth before they go public. Our platform enables you to diversify your portfolio with lower minimum investments in emerging healthcare technology leaders, making it easier to participate in the future of dental care innovation.

*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.